RT Journal Article
SR Electronic
T1 Dexmedetomidine withdrawal syndrome and opioid sensitivity
JF BMJ Supportive & Palliative Care
JO BMJ Support Palliat Care
FD British Medical Journal Publishing Group
SP bmjspcare-2020-002705
DO 10.1136/bmjspcare-2020-002705
A1 Lana Ferguson
A1 Stacey Hooper
YR 2020
UL http://spcare.bmj.com/content/early/2021/09/26/bmjspcare-2020-002705.abstract
AB This case report describes the use of dexmedetomidine for refractory cancer pain management in a patient with significant pelvic disease due to metastatic urothelial cancer. Specifically, the management of increased opioid sensitivity secondary to dexmedetomidine is discussed. Further, the phenomenon of dexmedetomidine withdrawal syndrome and our management of this is addressed.